U.S. markets close in 4 hours 31 minutes
  • S&P 500

    4,402.93
    +1.47 (+0.03%)
     
  • Dow 30

    35,006.89
    -51.63 (-0.15%)
     
  • Nasdaq

    14,753.63
    +93.05 (+0.63%)
     
  • Russell 2000

    2,203.13
    +11.30 (+0.52%)
     
  • Crude Oil

    72.09
    +0.44 (+0.61%)
     
  • Gold

    1,799.50
    -0.30 (-0.02%)
     
  • Silver

    24.92
    +0.28 (+1.12%)
     
  • EUR/USD

    1.1815
    -0.0011 (-0.09%)
     
  • 10-Yr Bond

    1.2580
    +0.0240 (+1.94%)
     
  • GBP/USD

    1.3875
    -0.0004 (-0.03%)
     
  • USD/JPY

    110.0830
    +0.3160 (+0.29%)
     
  • BTC-USD

    39,613.66
    +1,298.33 (+3.39%)
     
  • CMC Crypto 200

    930.11
    +0.18 (+0.02%)
     
  • FTSE 100

    7,017.35
    +21.27 (+0.30%)
     
  • Nikkei 225

    27,581.66
    -388.56 (-1.39%)
     

Co-diagnostics Inc (CODX) CEO Dwight H Egan Sold $1.4 million of Shares

·1 min read

- By insider

CEO of Co-diagnostics Inc (30-Year Financial, Insider Trades) Dwight H Egan (insider trades) sold 134,350 shares of CODX on 11/24/2020 at an average price of $10.55 a share. The total sale was $1.4 million.


Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests. Co-Diagnostics Inc has a market cap of $298.523 million; its shares were traded at around $10.56 with a P/E ratio of 11.73 and P/S ratio of 6.45. GuruFocus has detected 2 severe warning signs with Co-Diagnostics Inc. .

CEO Recent Trades:

  • CEO Dwight H Egan sold 134,350 shares of CODX stock on 11/24/2020 at the average price of $10.55. The price of the stock has increased by 0.09% since.

For the complete insider trading history of CODX, click here

.This article first appeared on GuruFocus.